Other groups have reported increased FOXA1 mRNA expression in colorectal tumors (20), anaplastic thyroid carcinoma (21), and esophageal and lung adenocarcinomas (LUAD; ref. 22) pointing to a potential oncogenic role for FOXA1 in these tumor lineages. Here, FOXA1 is linked to neoplasm.